C. Lochrin

850 total citations
15 papers, 336 citations indexed

About

C. Lochrin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, C. Lochrin has authored 15 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in C. Lochrin's work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Head and Neck Cancer Studies (3 papers). C. Lochrin is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Head and Neck Cancer Studies (3 papers). C. Lochrin collaborates with scholars based in Canada, United Kingdom and United States. C. Lochrin's co-authors include Peter Dixon, Andrea Bezjak, Michael Palmer, Joseph L. Pater, Liam Mulroy, James R. Wright, C. Grafton, Michael Brundage, Paul Blood and Colum J Smith and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Physics in Medicine and Biology and Medical Physics.

In The Last Decade

C. Lochrin

15 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Lochrin Canada 9 214 99 88 81 69 15 336
C. Koning Netherlands 6 268 1.3× 159 1.6× 73 0.8× 73 0.9× 40 0.6× 8 353
Caitlin A. Schonewolf United States 10 209 1.0× 72 0.7× 90 1.0× 96 1.2× 74 1.1× 37 376
Joel Sherman United States 5 149 0.7× 58 0.6× 46 0.5× 94 1.2× 126 1.8× 8 338
Gabriele Beckmann Germany 9 229 1.1× 97 1.0× 140 1.6× 85 1.0× 133 1.9× 19 395
Drexell H. Boggs United States 11 163 0.8× 117 1.2× 92 1.0× 87 1.1× 90 1.3× 30 315
Joanne Meng Canada 6 380 1.8× 176 1.8× 176 2.0× 166 2.0× 82 1.2× 7 508
Eli D. Scher United States 7 227 1.1× 96 1.0× 143 1.6× 112 1.4× 142 2.1× 14 406
Stephen Greco United States 10 227 1.1× 60 0.6× 68 0.8× 128 1.6× 46 0.7× 32 359
Theodore J. Robnett United States 7 407 1.9× 138 1.4× 146 1.7× 181 2.2× 39 0.6× 9 518
Qiuan Yang China 11 311 1.5× 82 0.8× 178 2.0× 109 1.3× 131 1.9× 23 445

Countries citing papers authored by C. Lochrin

Since Specialization
Citations

This map shows the geographic impact of C. Lochrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Lochrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Lochrin more than expected).

Fields of papers citing papers by C. Lochrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Lochrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Lochrin. The network helps show where C. Lochrin may publish in the future.

Co-authorship network of co-authors of C. Lochrin

This figure shows the co-authorship network connecting the top 25 collaborators of C. Lochrin. A scholar is included among the top collaborators of C. Lochrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Lochrin. C. Lochrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Croke, Jennifer, Michael M. Vickers, Daniel Yick Chin Heng, et al.. (2012). Continuity Clinics in Oncology Training Programs in Canada. Current Oncology. 19(5). 329–342. 5 indexed citations
2.
Cygler, Joanna, C. Lochrin, B. Esche, et al.. (2005). Clinical use of a commercial Monte Carlo treatment planning system for electron beams. Physics in Medicine and Biology. 50(5). 1029–1034. 36 indexed citations
3.
Cygler, Joanna, et al.. (2005). SU-FF-T-287: Effect of Tissue Inhomogeneitis on MU Required to Deliver Prescribed Dose - Monte Carlo Study. Medical Physics. 32(6Part11). 2016–2016. 1 indexed citations
4.
Bezjak, Andrea, Peter Dixon, Michael Brundage, et al.. (2002). Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15). International Journal of Radiation Oncology*Biology*Physics. 54(3). 719–728. 117 indexed citations
5.
Bezjak, Andrea, Peter Dixon, Michael Brundage, et al.. (2001). Randomized study of single versus fractionated radiotherapy (RT) in the palliation of non-small cell lung cancer; NCIC CTG SC.15. International Journal of Radiation Oncology*Biology*Physics. 51(3). 20–20. 8 indexed citations
6.
Alsbeih, Ghazi, Shawn Malone, C. Lochrin, et al.. (2000). Correlation between normal tissue complications and in vitro radiosensitivity of skin fibroblasts derived from radiotherapy patients treated for variety of tumors. International Journal of Radiation Oncology*Biology*Physics. 46(1). 143–152. 31 indexed citations
7.
Dixon, Peter, Michael Brundage, Michael Palmer, et al.. (2000). Characteristics of lung cancer patients entered on a Canadian palliative radiotherapy study (National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) SC.15 study). Lung Cancer. 29(1). 171–171. 8 indexed citations
8.
Lochrin, C., Glenwood Goss, David J. Stewart, et al.. (1999). Concurrent chemotherapy with hyperfractionated accelerated thoracic irradiation in stage III non-small cell lung cancer. Lung Cancer. 23(1). 19–30. 5 indexed citations
9.
Lochrin, C., et al.. (1997). Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.. PubMed. 1(5). 366–78. 21 indexed citations
10.
Goss, Greg G., C. Lochrin, S. Gertler, et al.. (1997). 168 A pilot study of high dose chemotherapy and irradiation with NEUPOGEN (G-CSF) in limited disease small cell lung cancer (SCLC). Lung Cancer. 18. 45–45. 1 indexed citations
11.
Goss, Glenwood, Simone Dahrouge, & C. Lochrin. (1996). Recent advances in the treatment of non-small cell lung cancer. Anti-Cancer Drugs. 7(4). 363–385. 8 indexed citations
12.
Turner, Sandra, C. Lochrin, Stanley Dische, M.I. Saunders, & E.J. Maher. (1995). Continuous hyperfractionated accelerated radiotherapy in the treatment of carcinoma of the columella and vestibule of the nose. European Journal of Cancer Part B Oral Oncology. 31(6). 368–372. 6 indexed citations
13.
Mackillop, W.J., Peter Dixon, Yunzheng Zhou, et al.. (1994). Variations in the management and outcome of non-small cell lung cancer in Ontario. Radiotherapy and Oncology. 32(2). 106–115. 44 indexed citations
14.
Lochrin, C., George D. Wilson, Nicolas J. McNally, Stanley Dische, & Michele I. Saunders. (1992). Tumor cell kinetics, local tumor control, and accelerated radiotherapy: A preliminary report. International Journal of Radiation Oncology*Biology*Physics. 24(1). 87–91. 36 indexed citations
15.
D’Angio, Giulio J., Audrey E. Evans, & C. Lochrin. (1989). Esthesioneuroblastoma. Medical and Pediatric Oncology. 17(5-6). 433–438. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026